Biglycan stimulates retinal pathological angiogenesis via up‐regulation of CXCL12 expression in pericytes
The FASEB Journal · 15.01.2025 · 39 (1)
DOI: 10.1096/fj.202401903r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 06.01.2025. Verfasst von Miaomiao Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Pericytes, Chemokine CXCL12, Biglycan, Up-Regulation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Open Project of Sichuan Provincial Key Laboratory for Human Disease Gene Study, National Natural Science Foundation of China.
Abstract (Originalsprache)
Retinal pathological angiogenesis (PA) is a common hallmark in proliferative retinopathies, including age‐related macular degeneration (AMD), proliferative diabetic retinopathy (PDR), and retinopathy of prematurity (ROP). The mechanisms underlying PA is complex and incompletely understood. In this study, we investigated the role of extracellular matrix (ECM) protein biglycan (BGN) in PA using an oxygen‐induced retinopathy (OIR) mouse model, along with hypoxia (1% O 2 ) conditions for incubating pericytes and endothelial cells in vitro. We found a significant upregulation of Bgn in the retinas of OIR mice. Intravitreal injection of Bgn ‐specific small interfering RNA (siRNA) in OIR mice at postnatal day 12 (P12) effectively curbed retinal PA at P17. Using cultured cells, we found that BGN expression in pericytes was highly sensitive to hypoxic stimulation compared to endothelial cells. We further showed that BGN stimulated retinal PA via the upregulation of C‐X‐C motif chemokine ligand 12 (CXCL12). Inhibition of the CXCL12‐CXCR4 axis effectively diminished PA in OIR mouse. In conclusion, our study demonstrated the stimulatory role of BGN in retinal PA, identified the link between BGN and CXCL12 expression, and further highlighted the role of pericytes in retinal PA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Naval Healthcare Information Center, PLA Naval Medical University, Shanghai, China.
- Department of Ophthalmology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Changxing Branch, Shanghai, China.
ORCID-Profile: Miaomiao Liu, Peiquan Zhao, Huazhang Feng, Xuerui Zhang, Ping Fei
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Open Project of Sichuan Provincial Key Laboratory for Human Disease Gene Study
- National Natural Science Foundation of China
Zitieren
APA
Liu, M., Zhao, P., Feng, H., Yang, Y., Zhang, X., Chen, E., Xiao, H., Luo, J., Chen, H., Yin, J., Lin, M., Mao, R., Zhu, X., Li, J., & Fei, P. (2025). Biglycan stimulates retinal pathological angiogenesis via up‐regulation of CXCL12 expression in pericytes. The FASEB Journal, 39(1). https://doi.org/10.1096/fj.202401903r
Vancouver
Liu M, Zhao P, Feng H, Yang Y, Zhang X, Chen E, et al. Biglycan stimulates retinal pathological angiogenesis via up‐regulation of CXCL12 expression in pericytes. The FASEB Journal. 2025;39(1). doi:10.1096/fj.202401903r
BibTeX
@article{Liu2025,
author = {Liu, Miaomiao and Zhao, Peiquan and Feng, Huazhang and Yang, Yuan and Zhang, Xuerui and Chen, Enguang and Xiao, Haodong and Luo, Jia and Chen, Han and Yin, Jiawei and Lin, Min and Mao, Ruixue and Zhu, Xingping and Li, Jing and Fei, Ping},
title = {Biglycan stimulates retinal pathological angiogenesis via up‐regulation of CXCL12 expression in pericytes},
journal = {The FASEB Journal},
year = {2025},
volume = {39},
number = {1},
doi = {10.1096/fj.202401903r}
}
EUVIMED